Vascular disrupting and antiangiogenic agents: better together than on their own

Raúl Gómez

doi:10.1016/j.fertnstert.2013.07.2001

Vascular disrupting and antiangiogenic agents: better together than on their own

Raúl Gómez

Fertility and sterility · 2013 · vol. 100(5) , pp. 1234–1235 · doi:10.1016/j.fertnstert.2013.07.2001 · PMID:23993886 · W2117066548

letter OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Capillaries Endometriosis Endometrium Endometrium Neovascularization, Pathologic Stilbenes Animals Capillaries Endometriosis Endometrium Female Stilbenes

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (6)

Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises via openalex
Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia via openalex
W2042299463 via openalex
W2071526086 via openalex
W2094642124 via openalex
W4251890925 via openalex

Source provenance

europepmc: last seen: 2026-06-17T06:13:18.893374+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:18:53.335890+00:00

License: CC0 · commercial use OK

[1] Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia 2010

[2] Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises 2008